Sensors for Health: Reimagining Diagnostics
Disposable NFC Immunoassays
Disposable immunoassays—diagnostic tests for proteins that correspond to specific biomarkers, allergens, infectious diseases, and even cancerous cells—can be combined with custom disposable NFC wireless chips to allow rapid, on-the-go testing using mobile devices.
Disposable Lab-On-A-Chip
Disposable lab-on-a-chip technology can be combined with low cost NFC for advanced, on-the-spot diagnostics using smartphones.
Modular Sensors for Phones
Gentag has a number of patents on sensor arrays for cell phones that can be used to detect specific chemicals—or combinations of chemicals—that cause allergic reactions.
Working to Improve Global Health and Compliance
By creating low-cost wireless health sensors that can be read directly with smartphones—enabling easy an-home health and drug compliance monitoring—Gentag is working to reduce global healthcare costs.
IoT and Blockchain
Gentag is introducing a revolutionary patented concept to reduce even further the costs of using sensors for the Internet of Things (IoT). Printable chemistries can become blockchain sensors, enabling new associated services such as authentication and payments.
Gentag’s pathbreaking IP now covers NFC sensors for food and beverage safety, packaging, and counterfeit prevention
April 30, 2019Read moreWASHINGTON, DC. April 30, 2019. Gentag’s pathbreaking IP now covers NFC sensors for food and beverage safety, packaging, and counterfeit prevention Gentag, Inc. (www.gentag.com) is pleased to announce the issuance of its latest patent, US patent 10,271,738. This broadly applicable new patent covers wireless NFC sensors for the detection and monitoring of bacteria, odors, temperature, specific chemistries or moisture levels
3Gentag’s IP now covers all key areas of wireless diagnostics including diagnostic skin patches, immunoassays and lab-on-a-chip technologies.
November 10, 2017Read moreWASHINGTON, Nov. 13, 2017 /PRNewswire/ — Gentag, Inc. is pleased to announce the issuance of 30 additional patents in Europe covering wireless lab-on- a-chip (LOC) diagnostic devices. The company now holds over 100 issued patents covering cell-based consumer and medical diagnostics that are at the apex of personalized medicine, telemedicine and point-of- care testing. These combined technologies allow a range
Gentag Announces Lab-on-a-Chip (LOC) Patent For Diagnostics With Cell Phones (NFC)
October 18, 2016Read moreThis new platform could make accurate point-of-care diagnostics instantly available to anyone with a cell phone. WASHINGTON, DC, October 18, 2016 — /PRNewswire/ — Gentag, Inc. is pleased to announce the issuance of U.S. Patent No. 9,470,699. This is the company’s seventy-sixth issued patent in the area of diagnostics with cell phones. This new patent, which covers both advanced biomarker